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Abstract
Background/Aims: ATP-gated P2X4 purinergic receptors (P2X4Rs) are cation channels 
with important roles in diverse cell types. To date, lack of specific inhibitors has hampered 
investigations on P2X4Rs. Recently, the benzodiazepine derivative, 5-BDBD has been 
proposed to selectively inhibit P2X4Rs. However, limited evidences are currently available on 
its inhibitory properties. Thus, we aimed to characterize the inhibitory effects of 5-BDBD on 
recombinant human P2X4Rs. Methods: We investigated ATP-induced intracellular Ca2+ signals 
and whole cell ion currents in HEK 293 cells that were either transiently or stably transfected 
with hP2X4Rs. Results: Our data show that ATP (< 1 μM) stimulates P2X4R-mediated Ca2+ 
influx while endogenously expressed P2Y receptors are not activated to any significant extent. 
Both 5-BDBD and TNP-ATP inhibit ATP-induced Ca2+ signals and inward ion currents in a 
concentration-dependent manner. Application of two different concentrations of 5-BDBD 
causes a rightward shift in ATP dose-response curve. Since the magnitude of maximal 
stimulation does not change, these data suggest that 5-BDBD may competitively inhibit 
the P2X4Rs. Conclusions: Our results demonstrate that application of submicromolar ATP 
concentrations allows reliable assessment of recombinant P2XR functions in HEK 293 cells. 
Furthermore, 5-BDBD and TNP-ATP have similar inhibitory potencies on the P2X4Rs although 
their mechanisms of actions are different.
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IntroductionExtracellular ATP and its breakdown products regulate a number of cellular functions by stimulating purinergic receptors [1]. In the last two decades 19 different purinergic 
receptors have been identified including four adenosine-activated P1 receptors, seven ATP-gated P2X receptor (P2XR) channels and eight metabotropic P2Y receptors which can be 
stimulated by adenosine and uridine tri- and diphosphates [2]. The seven P2X receptor subunits (P2X
1-7
) are widely distributed in both excitable and 
non-excitable cells providing cation permeable pathways (mainly for Ca2+ and Na+) through the plasma membrane. Previous studies revealed that these subunits might assemble as 
either homo- or heterotrimeric receptors [2]. Importantly, heteromerization can change functional and pharmacological properties of the P2XRs [2]. P2XRs are involved in 
presynaptic and postsynaptic actions of ATP [3-5] including taste sensation [6], hearing [7] and chemoreception [8]. P2XRs are also necessary for proper function of immune system 
[9]. In cardiovascular, respiratory, genitourinary and gastrointestinal systems several P2X receptor subunits seem to play pivotal role in both endothelial and epithelial cell functions 
[10]. Using pharmacological approaches and knockout animals, it has also become evident that P2XRs are involved in a broad range of pathophysiological processes such as chronic 
and inflammatory pain [11-15] arthritis [16] male infertility [17] and hypertension [18, 19]. A role for P2X4 receptors has been proposed in neuropathic pain [15], endothelial 
NO production [18], regulation of airway ciliary epithelia [20] and chloride secretion of 
respiratory [21, 22] and biliary epithelia [23]. However, validation of P2X4R involvement has 
been often hampered by the lack of specific inhibitors. In fact, P2X4 receptors are insensitive 
to the nonselective inhibitors, such as suramin and PPADS [24]. TNP-ATP has been found as a putative antagonist of P2X4 receptors. However, it blocks other P2X subtypes as well, such as P2X1, P2X2 and P2X3 [25]. Furthermore, TNP-ATP has been shown to be a weak blocker of P2X4 receptors (IC50  = 15 μM for 10 μM ATP stimulation) compared to its inhibitory potency at P2X1 and P2X3 receptors [26].
The benzodiazepine derivative, 5-(3-bromophenyl)-1,3-dihydro-2H-benzofuro[3,2-e]-
1,4-diazepin-2-one (5-BDBD), has been recently shown to selectively inhibit P2X4 receptors 
(IC
50  
~ 0.5 µM) [27]. Nonetheless, these results are described in a patent and details of the 
experimental procedure are not available. So far, limited experience has been available with 
5-BDBD and there is no consensus about its pharmacologically relevant concentration range. 
In some studies low micromolar (5-10 μM) concentrations were used [28, 29] whereas 
others applied significantly higher doses of 5-BDBD (30-100 μM) [30, 31]. 
In the present study, we investigated ATP-induced cytosolic Ca2+ signals and inward 
ion currents in HEK 293 cells transfected either transiently or stably with hP2X4 receptors. 
We characterized P2X4 receptor-mediated whole cell ion currents and identified P2YR- 
and P2XR-dependent calcium signals using electrophysiological and fluorescence ion 
measurement techniques, respectively. Despite endogenous expression of P2YRs we were 
able to discern P2XR-dependent Ca2+ signals stimulating the cells with submicromolar 
concentrations of ATP. We also assessed the inhibitory effects of 5-BDBD and TNP-ATP on 
both intracellular Ca2+ signals and inward ion currents. Our data suggest that 5-BDBD and 
TNP-ATP have similar inhibitory potencies on P2X4Rs. Furthermore, we show that 5-BDBD functions as a competitive antagonist of hP2X4Rs. 
Materials and Methods
Materials 
Cell culture medium, fetal bovine serum, cell culture supplements and antibiotics were purchased 
from Csertex Inc. (Budapest, Hungary). TurboFect™ in vitro Transfection Reagent was purchased from 
Biocenter (Szeged, Hungary). Lipofectamine 2000 was obtained from Invitrogen (Life Technologies Europe 
B.V, Zug, Switzerland). Fluo-3/AM was purchased from Invitrogen Inc. (Carlsbad, CA). 5-BDBD was obtained 
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from Tocris Inc. (Minneapolis, USA). Calcium-5 was purchased from Molecular Devices (Molecular Devices 
LLC, Sunnyvale, CA, USA). Ivermectin (IVM) was obtained from Merck AG (Merck, Zug, Switzerland). All 
other chemicals were purchased from Sigma-Chemical (St. Louis, MO).
DNA ConstructThe human P2X4R (imaGenes GmbH, Berlin, Germany) was amplified from human cDNA with the 
following primer pair: 5’-TAT AAG ATC TCG CGG CCA TGG CGG GC-3’, 
5’-TAT AGA ATT CCC TGG TCC AGC TCA CTA GCA AGA CCC TGC-3’
The amplified product was subcloned into the pmCherry-N1 (Clontech Laboratories Inc.) vector by 
using BglII and EcoRI restrictions sites. Amino acid sequence of the human P2X4 receptors fully corresponds 
to the isoform 3 described in gene database of the National Institute of Health.
Cell culture and establishment pmCherry-N1-hP2X4 expressing HEK 293 cell clones
Human embryonic kidney (HEK) 293 cells were grown in plastic tissue culture flasks in DMEM/
Ham’s F-12 (1:1) medium supplemented with 5% fetal bovine serum, 100 U/ml penicillin and 100µg/
ml streptomycin at 37°C in a cell culture incubator supplied with 5% CO2. Cells were subcultivated when 
confluency reached 90-95%. To establish pmCherry-N1-hP2X4 expressing HEK 293 cell clones, cells plated 
the day before on poly-D-lysine coated 35 mm dish were transfected with 2 µg pmCherry-N1-hP2X4 using 
5 µl Lipofectamine 2000 per well as described in the manufacturer’s protocol. Transfection medium was 
changed to antibiotic-free medium after 4 hours. On the following day the medium was then changed with 
selection antibiotic (G418) containing medium. From then on, the cells were kept in this selection medium. 
After a massive cell death of the non-transfected cells, surviving cells were trypsinized and replated in 
a 96-well plate at such a dilution that 1 cell/well density was obtained. After several days, colonies of 
cells displaying red fluorescence were selected as hP2X4-expressing positive clones using fluorescence microscopy.
Transient transfection
Before the day of transfection, cells were plated on poly-D-lysine coated round glass coverslips (25 mm 
in diameter) at a density of 500,000 cells in 40 mm plastic Petri dishes. After 16-24 h, cells were transfected 
with 3µg pmCherry-N1-hP2X4 DNA and 5µl of TurboFect™ transfection reagent in 200µl of serum-free 
medium. Cells were subjected to experiments 16-48 h after transfection. The efficiency of transfection was 
60-70%.
Cell surface biotinylation and western blottingP2X4 expressing HEK 293 cell clones were plated at 1.000.000 cell density into poly-D-lysine coated 60 
mm dishes. 24 hours after plating, cells were rinsed with ice-cold PBS-Ca-Mg (PBS containing 0.1 mM CaCl2 
and 1 mM MgCl2) followed by biotinylation of proteins at the plasma membrane with 1.5 mg/ml sulfo-NHS-
LC-biotin in 10 mM triethanolamine (pH 7.4), 1 mM MgCl2, 2 mM CaCl2, and 150 mM NaCl for 90 minutes 
with horizontal shaking at 4°C. Next, excess biotin was quenched with PBS containing 1 mM MgCl2, 0.1 mM 
CaCl2, and 100 mM glycine for 20 minutes at 4°C, and then rinsed three times with PBS. Cells were finally lysed in lysis buffer for 30 minutes and lysates were cleared by centrifugation. Protein concentrations were 
determined by DC Protein Assay. Portion of cell lysates of equivalent amounts of protein (1.33 mg/ml) 
were equilibrated overnight with streptavidin agarose beads at 4°C. Beads were washed sequentially with 
solutions A [50 mM Tris·HCl (pH 7.4), 100 mM NaCl, and 5 mM EDTA] three times, B [50 mM Tris·HCl (pH 
7.4) and 500 mM NaCl] twice, and C (50 mM Tris·HCl, pH 7.4) once. Biotinylated surface proteins were 
then released by heating to 95°C with 4x Laemmli buffer. Proteins from the intracellular fraction were also 
heated to 95°C for 5 minutes with 4x Laemmli buffer.
Samples were run on a 10% SDS gel with 40 µl protein loaded from the cytosolic protein (1 mg/ml) 
and the plasma membrane samples. Samples were transferred onto a PVDF membrane in Towbin’s buffer 
using the semi-dry transfer method. Membranes were blocked with PBS containing 5% milk, 0.5% BSA 
and 0.02% NaN3 at room temperature for 1 hour. Afterwards, samples were incubated in blocking solution 
containing the appropriate primary antibody (1:1000 for mouse anti-mCherry (Clontech, 632543)) at 4°C 
for overnight followed by three washes with PBST. HRP-conjugated goat anti-mouse antibody (1:4000, 
BioRad) was used as secondary antibody. After three consecutive washes with PBST and a final wash 
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with PBS, the enhanced chemiluminescence (ECL) method was used for detection. For loading control the 
membrane probed with anti-mCherry was stripped and blotted with avidin-HRP (1:1000, BioRad). 
HistochemistryAfter 24 hours of plating 400.000 P2X4-expressing HEK 293 clonal cells into a 35 mm dish, cells were 
washed thoroughly with PBS. Next, cells were incubated with 0.1 mg/ml LC-sulfo-NHS(+)-biotin (Molbio) at 
room temperature for 1 hour followed by three washes with PBS. Thereafter, cells were fixed with 4% PFA at 
370C for 15 minutes. Cells were washed three times with PBS before staining with Streptavidin conjugated to 
Alexa 488 (1:4000 dilution, Invitrogen) at room temperature for one hour. After washing the cells four times 
with PBS, samples were mounted with CitiFluor AF2 (EMS). Images were captured with a Nikon C1 confocal 
laser scanning microscopy system equipped with Multiline Argon and HeNe lasers using 40x magnification.
Measurement of intracellular calcium levels
Transiently transfected HEK 293 cells were loaded with Fluo-3/AM (4µl) in standard extracellular 
solution for 45 min at room temperature. Fluorescence dye was dissolved in DMSO containing 20% 
Pluronic-F127. Additionally, the loading solution contained 1 mM probenecid to prevent dye leakage. 
After dye loading, cells were washed with standard extracellular solution. Standard extracellular solution 
contained (in mM): 145 NaCl, 5 KCl, 2 CaCl2, 1 MgCl2, 10 D-glucose and 10 HEPES, pH 7.4 (with NaOH). 
Nominally Ca2+-free solutions were prepared by simply omitting CaCl2.
Measurements were performed with a Axiovert 200 M Zeiss LSM 510 Meta (Carl Zeiss, Jena, Germany) 
confocal laser scanning microscope equipped with a 20x Plan Apochromat (NA=0.80) DIC objective. For 
the excitation, 488-nm argon-ion laser was used. The emitted light was collected with BP 505-570 band 
pass filter. Data were obtained at a rate of 0.5 Hz. Changes in [Ca2+]i are displayed as the percentage of 
fluorescence relative to the intensity at the beginning of each experiment. The baseline fluorescence (100 
%) was calculated from the average fluorescence of ROIs while bathing the cells with standard extracellular 
solution. Background fluorescence was subtracted from fluorescence intensity by measuring a cell-free area on every coverslip. Agonists and antagonists were administered directly to the solution at the desired 
concentrations. All experiments were done at room temperature (22-24 oC).
Fluorescence ion measurement experiments using FLIPRTetra
Cells were trypsinized and plated at 40,000 cells/well density in 100 µl volume onto 96-well black 
plates coated with 100µg/ml poly-D-lysine 36 hours before the experiments. HEK 293 cells were used for testing the effects of compounds on endogenous P2Y receptors; whereas P2X4 activity was measured using P2X4-expressing HEK 293 cell clones. 36 hours later the medium was replaced with 100 µl of loading buffer 
(modified Krebs buffer containing 117 mM NaCl, 4,8 mM KCl, 1 mM CaCl2,1 mM MgCl2, 5 mM D-glucose, 10 
mM HEPES, and Calcium-5 fluorescence dye). Cells were then incubated in the loading buffer at 37oC for one 
hour. Fluorescence calcium measurements were carried out using FLIPTetra high-throughput, fluorescence 
microplate reader. Cells were excited using a 470-495 nm LED module, and the emitted fluorescence signal 
was filtered with a 515-575 nm emission filter. After establishment of a stable baseline, cells were incubated 
with the compounds for five minutes followed by the administration of ATP with or without the tested compounds.
Electrophysiology
Voltage-clamp recordings were carried out in the standard whole-cell configuration using an Axopatch 
200B amplifier (Axon Instruments) [32]. Human P2X4-expressing cells were selected using a Diaphot 300 
inverted patch clamp microscope (Nikon) equipped with an epifluorescent attachment (Elektro-Optika, 
Érd, Hungary). Micropipettes were pulled by a P-97 Flaming-Brown type micropipette puller (Sutter 
Instrument) from borosilicate glass capillary tubes (Harvard Apparatus) and had a tip resistance of 3–6 
MΩ when filled with pipette solution. Patch pipette filling solution contained (in mM): 135 KCl, 5 NaCl, 
1 MgCl2, 1 EGTA, 10 HEPES and an appropriate concentration of CaCl2, to give free [Ca2+]i = 0.1 µM. Free 
[Ca2+]i was estimated using MaxChelator software (Stanford University, Palo Alto, USA). The pH was adjusted 
to 7.2 with KOH. Standard extracellular solution contained (in mM): 145 NaCl, 5 KCl, 2 CaCl2, 1 MgCl2, 10 
D-glucose, 10 HEPES, pH 7.4 (with NaOH). Solutions were delivered by continuous perfusion with a gravity-
fed delivery system. Antagonists were added to the bath solutions 3-5 min. prior to agonist application. 
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Experiments were performed at a holding potential of -60 mV. Command protocols and data acquisition 
were controlled by pClamp 6.03 software (Axon Instruments). Capacitative currents were compensated 
with analog compensation. Series resistance was accepted if lower than five times the pipette tip resistance. 
Analog data were filtered at 1 kHz with a low-pass Bessel filter and digitized at 5 kHz using a Digidata 1200 
interface board. Data were analyzed using Clampfit 6.03 and Microsoft Excel softwares. All experiments were performed at room temperature.
Data presentation 
Areas under the curve (AUC) values were calculated using the trapezoidal rule, in the first 4 minutes 
following agonist application (SigmaPlot 12.0 software). To estimate P2X receptor function, non-expressing 
cell responses were subtracted from the AUC values obtained in P2X4R expressing cells on the same coverslip. 
Antagonist concentration-inhibition curves were obtained by using progressively increasing 
antagonist concentrations and a fixed agonist concentration close to the EC
50
 unless otherwise stated. IC
50
 
values were calculated by least squares fitting to I = I0/[1 + (IC50/[Ant])-nH], where I and I0 represent peak responses in the presence and absence of antagonist at concentration [Ant]. 
Results were presented as means ± SEM of n observations if not otherwise indicated. Statistical 
significance was determined using paired Student’s t-test for parametric, whereas one-way ANOVA followed 
by Mann-Whitney U test for non-parametric variables. Differences were considered statistically significant 
when p < 0.05. Non-linear curve fitting was performed using the SigmaPlot 12.0 program.
Results
Localization and functional characterization of transfected hP2X4 receptors in HEK 293 
cells
In order to study the localization of transfected hP2X4 receptors in HEK 293 cells we used 
immunohistochemical techniques. Co-localization of biotinylated cell surface proteins and 
mCherry fluorescent protein suggested the expression of P2X4Rs in the plasma membrane 
(Fig. 1). Furthermore, cell surface biotinylation and western blotting were used to separate 
the cytosolic and membrane fractions of proteins in HEK 293 cells. The P2X4-bound mCherry protein was detected at the plasma membrane and its expression was not altered by the 
presence of ivermectin (Fig. 2A). In control experiment we used avidin-HRP-conjugated 
antibody to confirm the localization of proteins in the membrane fraction (Fig. 2B).  
Fig. 1. Cellular localiza-tion of P2X4Rs by im-munohistochemistry. 
Panel A: Cell surface 
proteins stained with LC-
sulfo-NHS(+)-biotin and 
streptavidin-Alexa488. 
Panel B: Fluorescence 
image of mCherry tagged P2X4Rs in HEK 293 cells. 
Panel C: Merged image 
showing co-localization of P2X4Rs and bioti-nylated cell surface pro-
teins. Panel D: Differ-ential interference con-
trast (DIC) image of the P2X4Rs expressing cells. 
Scale bar represents 
20 μm.
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To functionally characterize the plasma membrane localized hP2X4 receptors we 
measured whole cell currents in transfected HEK 293 cells. ATP (0.1-300 μM) elicited increasing maximal current amplitudes in cells expressing P2X4Rs (Fig. 2C and D). The 
agonist concentration-response curve for ATP were fit with the Hill-equation; E = Emax[1 + 
(EC
50
/[A])nH] where E stands for the peak current evoked by agonist concentration [A], Emax is 
the peak current evoked by a maximal agonist concentration, EC
50
 is the concentration giving 
half the maximal current, and nH represents the Hill coefficient. Our results showed that the 
EC
50
 value of ATP was 2.1 μM (Fig. 2D). Cells lacking P2X4R expression failed to respond 
to ATP (100 μM) (data not shown). To confirm the role of P2X4Rs in ATP-induced inward 
currents we pretreated the cells with ivermectin (IVM) (3 and 10 μM). As expected, IVM 
potentiated currents induced by ATP (0.5 μM) in a concentration-dependent manner (Fig. 
2E). In addition, we tested the effects of TNP-ATP on ATP-induced (1 μM) currents. Under 
these conditions, we found that the half-maximal inhibitory concentration (IC
50
) of TNP-ATP 
was 1.5 μM (Fig. 2F). These data show the plasma membrane localized hP2X4 receptors are 
fully functional in transfected HEK 293 cells.
Fig. 2. Localization and functional characterization of transfected hP2X4 receptors in HEK 293 cells. Panel 
A: Cytosolic and cell surface proteins were separated. Human P2X4Rs are expressed both in cytosolic (lanes 
1-4) and plasma membrane (lanes 5-8) fractions of proteins. Lane 1 and 5 indicate unstimulated cells, lanes 
2 and 6 DMSO-pretreated (1:1000) cells, lanes 3 and 7 IVM-pretreated (10 μM) cells and lanes 4 and 8 IVM-
pretreated (20 μM) cells. Panel B: In control experiments we obtained protein expression only in cell surface 
fraction (lanes 5-8) using avidin-HRP. Panel C: Representative traces showing ATP-induced inward currents 
in the absence; and panel E: presence of ivermectin (IVM). Panel D: Concentration-responses to ATP (0.1-
300 μM) are shown. Panel F: Concentration-inhibitions to TNP-ATP (0.05-50 μM) in ATP-stimulated (1 μM) 
cells are shown. Values are means ± SEM. The error bars are not always visible due to the small SEM values. Experiments at each concentration were performed at least 3 times. 
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ATP-induced Ca2+ influx is inhibited by 5-BDBD in cells stably expressing P2X4Rs
In native HEK 293 cells ATP (0.5-100 μM) caused transient increases in cytosolic calcium 
concentrations whereas lower doses of the agonist (0.1-0.25 μM) elicited no change in calcium 
levels (Fig 3A). In nominally calcium-free buffer ATP (0.1-100 μM) caused similar effects 
suggesting that the calcium signal was due to P2Y receptor-dependent Ca2+ release from the 
intracellular stores (Fig. 3B). Although the presence of external Ca2+ prolonged ATP-induced 
calcium signals, sustained responses could not been observed (Fig. 3A). Next, we studied 
ATP-induced Ca2+ signals in HEK 293 cell clones stably expressing P2X4Rs (see methods). In 
these cells ATP (0.1-0.25 μM) elicited changes in Ca2+ concentrations that were abolished in 
Ca2+-depleted medium indicating that Ca2+ entered the cells from the extracellular space (Fig. 
3C and D). In addition, higher concentrations of ATP (≥ 1μM) caused sustained Ca2+ signals 
(Fig. 3C). Importantly, the P2X4 receptor-specific positive allosteric modulator IVM (20 μM) 
potentiated the ATP-induced (0.25 μM) Ca2+ entry (AUCATP = 852 ± 47; n=5 vs. AUCATP+IVM = 
1026 ± 46; n=5; p<0.05). These data indicate that using low concentrations of ATP (≤0.25 μM) allows assessment of P2X4R-mediated Ca2+ signals independent of P2Y receptor activation. 
Thus, we next studied the effects of the benzodiazepine derivative 5-BDBD in the presence 
of 0.25 μM ATP. Under these conditions 5-BDBD (2-20 μM) significantly inhibited P2X4R-
mediated Ca2+ entry (Fig. 4A). We obtained similar inhibitory effects of 5-BDBD when cells 
were stimulated by 0.5 μM ATP (Fig. 4B). Regardless of ATP concentrations used, 5-BDBD 
(1-20 μM) had no effects in native HEK 293 cells suggesting that endogenously expressed P2Y receptors were not inhibited (data not shown). 
Fig. 3. ATP-induced changes of cytosolic calcium concentration measured using FLIPRTetra. Panels A and B: 
Administration of extracellular ATP induced dose-dependent, similar transient changes of cytosolic calcium 
in HEK 293 cells in the presence or absence of extracellular calcium. Panel C: In contrast, in HEK 293 cells stably expressing hP2X4 ATP-induced sustained calcium response in the presence of extracellular calcium 
Panel D: whereas in calcium-free buffer the responses were similar to the ones obtained in non-transfected 
cells. Average tracings of 6 individual experiments are shown. 
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Single cell calcium imaging in cells transiently expressing P2X4Rs 
Single cell calcium imaging has been shown to provide an alternative method for the 
assessment of P2X receptor channel activity [33]. Therefore, we also studied the ATP-
induced intracellular Ca2+ signals at the single cell level. In order to conduct simultaneous 
measurements of cytosolic Ca2+ levels in P2X4R-expressing and non-expressing cells, we used 
Fig. 4. 5-BDBD inhib-
ited the ATP-induced Ca2+ signals in HEK 293 cells stably expressing hP2X4 
receptors. Panels A and B: 
Concentration-dependent 
inhibition of Ca2+ signals 
by 5-BDBD when cells 
were stimulated with 0.25 
μM and 0.5 μM ATP. Values 
are means ± SD. Each expe-riment was performed at least 4 times. A.U. means arbitrary units. *p<0.05 and **p<0.005 vs. ATP po-
sitive controls (ANOVA).
Fig. 5. ATP induced concentration-dependent changes in [Ca2+]i in hP2X4-expressing and non-expressing 
HEK 293 cells. Panel A: Representative traces showing the effects of different ATP concentrations (0.1-
1μM) on [Ca2+]i Each experiment was performed at least 5 times; Panel B: P2XR:P2YR-mediated Ca2+ 
response ratios are shown at different ATP concentrations. P2YR-mediated responses were estimated by 
the amplitude of cytosolic Ca2+ peaks while P2XR-mediated responses were assessed by “area under the 
curve” (AUC) values referring to the sustained nature of the Ca2+ signal. S.E.M. values are not shown for the 
representative traces because they were within 10% of the mean. A.U. means arbitrary units. 
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the transient transfection method. First, we identified the extracellular ATP concentration 
at which P2XR:P2YR-mediated Ca2+ response ratio was the highest. The P2YR-mediated 
responses were estimated by the amplitude of cytosolic Ca2+ peaks while P2XR-mediated 
responses were assessed by “area under the curve” (AUC) values referring to the sustained 
nature of the Ca2+ signal. In cells lacking P2X4R expression, administration of 0.1 μM and 
0.5 μM ATP evoked small peak increases without sustained Ca2+ signals (Fig. 5A). In cells expressing P2X4Rs, the magnitude of Ca2+ peaks induced by 0.1 μM and 0.5 μM ATP were 
significantly higher than in non-expressing cells. However, robust Ca2+ plateau was induced 
only by 0.5 μM ATP (Fig. 5A). Further increasing ATP concentrations (1 μM), a considerable 
rise in cytosolic Ca2+ peak was observed in cells lacking P2X4R expression. In contrast, 
the sustained component of the Ca2+ signal induced by 1 μM ATP did not significantly 
differ from that elicited by 0.5 μM ATP in P2X4R expressing cells (Fig. 5A). Consequently, 
as P2XR:P2YR-mediated Ca2+ response ratio was the highest at 0.5 μM ATP (Fig. 5B), in 
subsequent experiments this concentration was chosen to investigate single cell Ca2+ signals. 
To demonstrate that extracellular Ca2+ was necessary for ATP-induced sustained Ca2+ signal in cells expressing P2X4Rs, we repeated the experiments in Ca2+-depleted medium. Under 
these circumstances, the Ca2+ signal was only transient suggesting that Ca2+ entry was due to functional expression of P2X4Rs (Fig. 6). In cells lacking P2X4R expression, external Ca2+ did 
not influence the ATP-induced transient nature of cytosolic Ca2+ signal (Fig. 6). These data 
excluded the possibility that store-operated calcium channels played significant role in Ca2+ 
entry when cells were stimulated with 0.5 μM ATP. To further characterize the sustained 
Ca2+ signal, we pretreated the cells with IVM (10 μM) 5 min prior the application of ATP. Our 
results showed that ATP-induced Ca2+ plateau was significantly elevated in P2X4R expressing 
but not in non-expressing cells (Fig. 6). 
Next, we tested the effects of 5-BDBD on ATP-induced (0.5 μM), P2X4R-mediated Ca2+ 
entry. Sustained Ca2+ signals were diminished in cells pretreated with different concentrations 
of 5-BDBD (0.5-20 μM). We observed 50% reduction of the AUC values in the presence of 
approx. 2 µM 5-BDBD (Fig. 7A). We also studied inhibitory effects of TNP-ATP which was reported as a putative antagonist of P2X4Rs [25]. As shown in Figure 7B, TNP-ATP (0.5-50 
μM) reduced ATP-induced (0.5 μM) sustained Ca2+ signal in a concentration-dependent 
manner. Taken together, these data indicate that ATP-induced sustained Ca2+ signals were 
inhibited by both 5-BDBD and TNP-ATP in HEK 293 cells transfected with P2X4Rs. 
Fig. 6. Top panels: ATP indu-
ced changes in [Ca2+]i in Ca2+-
containing or Ca2+-depleted 
medium. Bottom panels: 
Ivermectin (IVM) potentia-
ted the ATP-induced Ca2+ sig-nal only in hP2X4-expressing cells. 
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P2X4 receptor channels are competitively inhibited by 5-BDBD
Data presented in this paper show that 5-BDBD inhibited the P2X4R-mediated Ca2+ 
entry in both stably and transiently transfected HEK 293 cells (see above). Nonetheless, 
during measurements of intracellular Ca2+ concentrations activation of endogenous P2YRs 
and/or ion transporters that eliminate Ca2+ from the cytosol (i.e. plasma membrane Ca2+-
ATPase, sarcoplasmic reticulum Ca2+-ATPase) might possibly interfere with the effectiveness 
of 5-BDBD. Therefore, we also tested the inhibitory effects of 5-BDBD in HEK 293 cells using 
the whole cell configuration of the patch clamp technique. We stimulated the cells with 1 µM 
Fig. 7. Both 5-BDBD and 
TNP-ATP inhibited the ATP-
induced Ca2+ signals in HEK 293 cells transiently trans-fected with hP2X4 receptors. 
Panels A and B: Concent-
ration-dependent inhibiti-
on of the ATP-induced Ca2+ 
response by 5-BDBD (0.5-
20μM); and TNP-ATP (0.5-
50μM). The number of inde-pendent experiments is indi-cated in parenthesis beneath the columns. 
Fig. 8. 5-BDBD com-petitively inhibited the 
ATP-induced whole cell inward ion currents in 
HEK 293 cells transient-ly expressing hP2X4 re-ceptors. Panel A: Repre-sentative original traces showing the inhibitory 
effects of 5-BDBD at va-rious concentrations. 
Panel B: Concentration-dependent inhibition of 
5-BDBD (0.1-50 μM) in 
ATP-stimulated (1 μM) cells are shown. Panel 
C: Concentration-depen-dent responses to ATP 
(0.1-300 μM) in cells that were pretreated with 2 
or 20 μM 5-BDBD. The rightward shift of the ATP control curve and the unchanged maximal 
stimulation suggest that 5-BDBD competitively inhibited the P2X4 receptor channels. In the absence of 
5-BDBD the Hill coefficient was 1.26. In the presence of 2 μM and 20 μM 5-BDBD nH values were 1.11 and 
2.17, respectively. Values are means ± SEM. The error bars are not always visible due to the small SEM valu-es. Experiments at each concentration were performed at least 3 times.
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ATP (close to EC30 of ATP) because higher concentrations of the agonist induced premature 
cell damage in a number of experiments. Under these circumstances, 5-BDBD (0.1-50 µM) 
dose-dependently inhibited P2X4R-mediated inward currents (Icontrol: 1239 ± 105 pA, n=8 vs. I
0.5µM
: 983 ± 148 pA, n=4 vs. I
2µM
: 417 ± 33, n=4 vs. I
20µM
: 13 ± 1 pA, n=4) with an IC
50
 of 1.2 µM 
(Fig. 8A and B). To investigate whether the inhibitory effect of 5-BDBD was due to competitive or allosteric interaction with P2X4Rs, we performed additional electrophysiological 
experiments. Application of two different concentrations of 5-BDBD (2 µM and 20 µM) 
caused a rightward shift in ATP dose-response curve (from EC
50
 = 2.1 µM to 11.2 µM and 
79.2 µM, respectively, using non-linear regression analysis). Since the magnitude of maximal 
stimulation did not change, these data suggest that 5-BDBD competitively inhibited the P2X4Rs (Fig. 8C). 
DiscussionP2X4 receptors are involved in important physiological and pathophysiological 
functions such as afferent signalling, chronic pain and autocrine/paracrine communications 
of endothelial and epithelial cells. In these processes, investigations on the role of P2X4Rs 
are often hindered by lack of selective inhibitors. In recent years, considerable efforts have been made to discover novel effective antagonists of P2X4Rs. Although the benzodiazepine 
derivative 5-BDBD has been recently proposed to selectively block P2X4Rs [27], only limited 
experiences have been available concerning its inhibitory properties [28-31]. Moreover, to 
the best of our knowledge, there are no previous studies attempting to compare the inhibitory 
effects of 5-BDBD using both electrophysiological and intracellular calcium measurements. 
Therefore, we aimed to investigate the inhibitory potency of 5-BDBD on P2X4R-dependent 
Ca2+ entry. Our data provide evidence for competitive though moderate inhibitory effects of 
5-BDBD. Depending on experimental conditions the degree of inhibition varied significantly. 
In patch clamp experiments, assessing the effects of 5-BDBD directly on its target protein, we 
obtained the strongest inhibition. In intracellular calcium measurements, 5-BDBD exhibited more robust effects in transiently transfected cells. This was probably due to both the higher level of P2X4R expression and the single cell calcium measurements. However, it is important 
to emphasis that AUC values are not in a linear fashion with [Ca2+]i and quantitative analyses 
of fluorometric Ca2+ assay may provide only a rough orientation.
Despite the endogenous expression of at least three different P2Y receptor subtypes 
[34, 35] HEK 293 cells are frequently used to study properties of P2X receptors [34, 36]. 
To assess the role of P2XRs in inducing changes of intracellular Ca2+ concentrations, some 
investigators often choose cell lines (i.e. excitable mouse immortalized gonadotropin-
releasing hormone-secreting cells (GT1) and human astrocytoma cells (1321N1)) that are 
lacking P2Y receptors [33, 37]. Stojilkovic and his colleagues transfected both GT1 and 
HEK 293 cells with different P2X subtypes and compared ATP-induced Ca2+ signals. They 
concluded that intracellular Ca2+ measurements could be used for the characterization of 
P2X receptors only in GT1 but not in HEK 293 cells because activation of endogenously 
expressed P2Y receptors interferes with P2X receptor-mediated Ca2+ signals [33]. This is 
indeed the case when HEK 293 cells are stimulated with high concentrations of ATP (>10 μM). 
Nonetheless, here we propose an alternative approach to investigate P2XR functions in HEK 
293 cells applying low doses of agonist. In the present study, we show that submicromolar 
concentrations of ATP (≤ 0.25 µM) cause changes in intracellular Ca2+ concentrations solely in P2X4R expressing cells. The ATP-induced increase in Ca2+ concentrations was further 
enhanced by pretreatment of ivermectin and was completely abolished in Ca2+-depleted medium suggesting that P2X4Rs were involved in Ca2+ influx. Furthermore, we found that 
higher doses of ATP (≥1 µM) prolonged the duration of Ca2+ signals in native HEK 293 cells. 
These effects were abolished in Ca2+-depleted medium suggesting the activation of P2X4R-
independent Ca2+ influx mechanisms. The significantly higher initial phase of Ca2+ response in P2X4R expressing cells compared to native cells was probably due to the fact that we used 
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nominally Ca2+ free solutions. Nonetheless, according to our previous experience, we could 
not add calcium chelators because HEK 293 cells require extracellular Ca2+ to remain attached 
to the coverslip. We assume that, as a result of P2Y receptor-dependent Ca2+ release, store-
operated Ca2+ entry could contribute to the overall Ca2+ signal when cells are stimulated with 
higher concentrations of ATP (>1 µM). Therefore, our results suggest that when sufficiently 
low ATP concentrations are applied, measurement of intracellular Ca2+ concentrations is a 
useful approach to assess properties of P2XR in HEK 293 cells. 
Considering the fact that Ca2+ measurement in stably transfected cells did not allow concurrent investigations of the P2X4R-expressing and non-expressing cells, we also 
performed single cell calcium measurements in transiently transfected HEK 293 cells. Thus, 
we could simultaneously measure ATP-induced Ca2+ signals in P2X4R-expressing and non-expressing cells on the same coverslip. Our data suggest that up to the concentration of 
0.5 μM, ATP causes only small transient changes in Ca2+ concentration whereas 1 μM ATP 
significantly enhances the signal amplitude in non-expressing cells. This phenomenon was 
probably due to the gradual activation of different endogenous P2Y receptor subtypes [35]. 
To our surprise, we found that amplitudes of ATP-induced Ca2+ signals were significantly higher in P2X4R-expressing than in non-expressing cells when experiments were performed 
in Ca2+-depleted medium (Fig. 6). Since we obtained similar results in stably transfected cells 
as well, we speculate that the difference was due to P2X4R-mediated Ca2+ entry rather than 
additional release of Ca2+ from the internal stores. High levels of P2X4R-expression and lack 
of Ca2+-chelation could both contribute to the Ca2+ entry. Furthermore, our data show that 
IVM enhances the ATP-induced Ca2+ entry only in P2X4R-expressing cells. In accordance with 
previous observations, IVM potentiated ATP-induced Ca2+ entry but did not increase surface 
expression of P2X4Rs [38, 39]. 
Our electrophysiological data confirmed the presence of functional P2X4Rs in transiently 
transfected HEK 293 cells. ATP caused IVM-sensitive activation of inward currents in P2X4R-expressing but not in non-expressing cells. We found EC50 value of ATP close to what 
was previously reported [26]. However, it is noteworthy that, in some experiments ATP-stimulated currents exhibited incomplete recovery following withdrawal of the agonist 
when its concentration was higher than 1 µM. This was probably due to the high level of P2X4R expression and massive Ca2+ influx which could consequently cause cellular damage. 
Therefore, inhibitory properties of both TNP-ATP and 5-BDBD were tested at 1 µM ATP stimulation. Activation of P2X4Rs plays a key role in the pathogenesis of neuropathic pain [15]. In an attempt to mitigate the neuropathic pain Inoue and his colleagues investigated the possible role of antidepressants as inhibitors of P2X4Rs [37]. They found that paroxetine inhibited P2X4Rs dose-dependently. Paroxetine behaved as a noncompetitive antagonist with IC50 
values of 2.5 µM and 1.9 µM for rat and human P2X4Rs, respectively. Interestingly, inhibitory 
effects of paroxetine were significantly stronger on rat P2X4Rs than that of TNP-ATP [37]. It 
is known that TNP-ATP is more than 1,000-fold more potent in blocking P2X1 and P2X3 than P2X4 receptors [24]. Nonetheless, TNP-ATP has been used as P2X4 antagonist in a number 
of studies [40, 41]. Our data also demonstrate that TNP-ATP inhibits both intracellular Ca2+ 
signals and inward ion currents induced by ATP. We found that TNP-ATP had an IC
50
 value 
of 1.5 µM for 1 µM ATP stimulation which was comparable with previous observations [25]. 
Noncompetitive antagonism of TNP-ATP at the P2X3Rs suggests similar mechanisms of action at P2X4Rs as well [25]. 
Recently, 5-BDBD has been proposed to selectively inhibit P2X4Rs [27]. Since then 
5-BDBD has been used in a number of studies with contradictory results [28-31]. It has weak potency to inhibit recombinant human P2X4Rs [28] or native P2X4Rs in vascular endothelial 
cells (IC
50
 ~ 30 µM) [30]. In contrast, P2X4Rs were potently blocked by 10 µM 5-BDBD in 
prechondrogenic cell line [29]. Here we report that 5-BDBD and TNP-ATP have similar inhibitory potencies at recombinant human P2X4Rs expressed in HEK 293 cells. Our data 
suggest that 5-BDBD may competitively inhibit the P2X4Rs. However, we cannot exclude the 
possibility that 5-BDBD decreases the ligand-binding affinity of the channels. Such allosteric 
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alterations of ATP-binding affinity have been previously reported for P2X receptors [42, 43].
In conclusion, the present study demonstrates that intracellular measurement of Ca2+ 
concentration in HEK 293 cells could be a useful method to investigate pharmacological properties of P2X receptor antagonists provided that submicromolar concentrations of ATP 
are used. 5-BDBD and TNP-ATP have similar inhibitory potencies at human recombinant P2X4Rs. Our data show that 5-BDBD shifts the ATP concentration-response curve to the right. This feature differs from the previously described noncompetitive behavior of other P2X4R antagonists such as TNP-ATP and paroxetine. 
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